3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
33
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Bevacizumab
39
atezolizumab
26
durvalumab
24
Nivolumab
21
lenvatinib
20
tremelimumab
16
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
sintilimab
11
pembrolizumab
11
Ipilimumab
10
tislelizumab
7
X-Rays
7
Sorafenib
7
Immunoglobulin G
7
regorafenib
6
Disulfides
6
Cyclophosphamide
6
cabozantinib
5
Radiotherapy
5
Radiosurgery
5
Blood Specimen Collection
5
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Fluorouracil
4
Ethiodized Oil
4
Biopsy
4
fludarabine
3
donafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tamoxifen
×
90 days
×
Clear all
No trials found.